# US 2002/0160456 A1 · Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0160456 A1
- Document ID: US20020160456A1
- Status: Published application
- Kind: A1
- Application number: 09/895,913
- Filed: 2001-06-29
- Published: 2002-10-31
- Earliest claimed: 1997-06-24
- Inventors: Harold Kleanthous; Amal Al-Garawi; Charles Miller; Jean-Francois Tomb; Raymond P. Oomen
- Web page: https://patentgrep.com/patent/US20020160456A1

## CPC

- C07K 16/121: Helicobacter (G); Campylobacter (G)
- C07K 14/205: from Campylobacter (G)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention provides Helicobacter polypeptides that can be used in vaccination methods for preventing or treating Helicobacter infection, and polynucleotides that encode these polypeptides.

## Claims

### Claim 1

An isolated polynucleotide that encodes:
(i) a polypeptide comprising an amino acid sequence that is homologous to the amino acid sequence of a Helicobacter polypeptide selected from the group consisting of GHPO 15 (SEQ ID NO:2), GHPO 16 (SEQ ID NO:4), GHPO 36 (SEQ ID NO:6), GHPO 38 (SEQ ID NO:8), GHPO 52 (SEQ ID NO:10), GHPO 57 (SEQ ID NO:12), GHPO 64 (SEQ ID NO:14), GHPO 79 (SEQ ID NO:16), GHPO 84 (SEQ ID NO:18), GHPO 86 (SEQ ID NO:20), GHPO 99 (SEQ ID NO:22), GHPO 106 (SEQ ID NO:24), GHPO 118 (SEQ ID NO:26), GHPO 122 (SEQ ID NO:28), GHPO 128 (SEQ ID NO:30), GHPO 138 (SEQ ID NO:32), GHPO 153 (SEQ ID NO:34), GHPO 160 (SEQ ID NO:36), GHPO 168 (SEQ ID NO:38), GHPO 179 (SEQ ID NO:40), GHPO 189 (SEQ ID NO:42), GHPO 229 (SEQ ID NO:44), GHPO 243 (SEQ ID NO:46), GHPO 244 (SEQ ID NO:48), GHPO 251 (SEQ ID NO:50), GHPO 267 (SEQ ID NO:52), GHPO 269 (SEQ ID NO:54), GHPO 279 (SEQ ID NO:56), GHPO 284 (SEQ ID NO:58), GHPO 296 (SEQ ID NO:60), GHPO 300 (SEQ ID NO:62), GHPO 305 (SEQ ID NO:64), GHPO 319 (SEQ ID NO:66), GHPO 330 (SEQ ID NO:68), GHPO 340 (SEQ ID NO:70), GHPO 342 (SEQ ID NO:72), GHPO 344 (SEQ ID NO:74), GHPO 358 (SEQ ID NO:76), GHPO 373 (SEQ ID NO:78), GHPO 382 (SEQ ID NO:80), GHPO 384 (SEQ ID NO:82), GHPO 398 (SEQ ID NO:84), GHPO 409 (SEQ ID NO:86), GHPO 422 (SEQ ID NO:88), GHPO 430 (SEQ ID NO:90), GHPO 446 (SEQ ID NO:92), GHPO 447 (SEQ ID NO:94), GHPO 450 (SEQ ID NO:96), GHPO 451 (SEQ ID NO:98), GHPO 452 (SEQ ID NO:100), GHPO 456 (SEQ ID NO:102), GHPO 461 (SEQ ID NO:104), GHPO 476 (SEQ ID NO:106), GHPO 478 (SEQ ID NO:108), GHPO 491 (SEQ ID NO:110), GHPO 511 (SEQ ID NO:112), GHPO 519 (SEQ ID NO:114), GHPO 526 (SEQ ID NO:116), GHPO 534 (SEQ ID NO:118), GHPO 536 (SEQ ID NO:120), GHPO 542 (SEQ ID NO:122), GHPO 544 (SEQ ID NO:124), GHPO 576 (SEQ ID NO:126), GHPO 578 (SEQ ID NO:128), GHPO 580 (SEQ ID NO:130), GHPO 585 (SEQ ID NO:132), GHPO 599 (SEQ ID NO:134), GHPO 639 (SEQ ID NO:136), GHPO 642 (SEQ ID NO:138), GHPO 647 (SEQ ID NO:140), GHPO 654 (SEQ ID NO:142), GHPO 669 (SEQ ID NO:144), GHPO 710 (SEQ ID NO:146), GHPO 713 (SEQ ID NO:148), GHPO 716 (SEQ ID NO:150), GHPO 718 (SEQ ID NO:152), GHPO 726 (SEQ ID NO:154), GHPO 734 (SEQ ID NO:156), GHPO 740 (SEQ ID NO:158), GHPO 770 (SEQ ID NO:160), GHPO 782 (SEQ ID NO:162), GHPO 786 (SEQ ID NO:164), GHPO 792 (SEQ ID NO:166), GHPO 797 (SEQ ID NO:168), GHPO 816 (SEQ ID NO:170), GHPO 828 (SEQ ID NO:172), GHPO 839 (SEQ ID NO:174), GHPO 840 (SEQ ID NO:176), GHPO 842 (SEQ ID NO:178), GHPO 885 (SEQ ID NO:180), GHPO 889 (SEQ ID NO:182), GHPO 903 (SEQ ID NO:184), GHPO 912 (SEQ ID NO:186), GHPO 946 (SEQ ID NO:188), GHPO 958 (SEQ ID NO:190), GHPO 968 (SEQ ID NO:192), GHPO 987 (SEQ ID NO:194), GHPO 992 (SEQ ID NO:196), GHPO 996 (SEQ ID NO:198), GHPO 997 (SEQ ID NO:200), GHPO 1002 (SEQ ID NO:202), GHPO 1026 (SEQ ID NO:204), GHPO 1028 (SEQ ID NO:206), GHPO 1034 (SEQ ID NO:208), GHPO 1038 (SEQ ID NO:210), GHPO 1059 (SEQ ID NO:212), GHPO 1065 (SEQ ID NO:214), GHPO 1072 (SEQ ID NO:216), GHPO 1073 (SEQ ID NO:218), GHPO 1088 (SEQ ID NO:220), GHPO 1091 (SEQ ID NO:222), GHPO 1105 (SEQ ID NO:224), GHPO 1115 (SEQ ID NO:226), GHPO 1159 (SEQ ID NO:228), GHPO 1177 (SEQ ID NO:230), GHPO 1187 (SEQ ID NO:232), GHPO 1192 (SEQ ID NO:234), GHPO 1195 (SEQ ID NO:236), GHPO 1224 (SEQ ID NO:238), GHPO 1225 (SEQ ID NO:240), GHPO 1228 (SEQ ID NO:242), GHPO 1229 (SEQ ID NO:244), GHPO 1231 (SEQ ID NO:246), GHPO 1236 (SEQ ID NO:248), GHPO 1242 (SEQ ID NO:250), GHPO 1248 (SEQ ID NO:252), GHPO 1270 (SEQ ID NO:254), GHPO 1271 (SEQ ID NO:256), GHPO 1298 (SEQ ID NO:258), GHPO 1301 (SEQ ID NO:260), GHPO 1304 (SEQ ID NO:262), GHPO 1315 (SEQ ID NO:264), GHPO 1319 (SEQ ID NO:266), GHPO 1323 (SEQ ID NO:268), GHPO 1331 (SEQ ID NO:270), GHPO 1332 (SEQ ID NO:272), GHPO 1347 (SEQ ID NO:274), GHPO 1373 (SEQ ID NO:276), GHPO 1376 (SEQ ID NO:278), GHPO 1380 (SEQ ID NO:280), GHPO 1394 (SEQ ID NO:282), GHPO 1407 (SEQ ID NO:284), GHPO 1415 (SEQ ID NO:286), GHPO 1425 (SEQ ID NO:288), GHPO 1427 (SEQ ID NO:290), GHPO 1444 (SEQ ID NO:292), GHPO 1449 (SEQ ID NO:294), GHPO 1465 (SEQ ID NO:296), GHPO 1475 (SEQ ID NO:298), GHPO 1479 (SEQ ID NO:300), GHPO 1483 (SEQ ID NO:302), GHPO 1488 (SEQ ID NO:304), GHPO 1496 (SEQ ID NO:306), GHPO 1524 (SEQ ID NO:308), GHPO 1536 (SEQ ID NO:310), GHPO 1539 (SEQ ID NO:312), GHPO 1540 (SEQ ID NO:314), GHPO 1542 (SEQ ID NO:316), GHPO 1555 (SEQ ID NO:318), GHPO 1560 (SEQ ID NO:320), GHPO 1564 (SEQ ID NO:322), GHPO 1570 (SEQ ID NO:324), GHPO 1588 (SEQ ID NO:326), GHPO 1604 (SEQ ID NO:328), GHPO 1605 (SEQ ID NO:330), GHPO 1619 (SEQ ID NO:332), GHPO 1629 (SEQ ID NO:334), GHPO 1642 (SEQ ID NO:336), GHPO 1654 (SEQ ID NO:338), GHPO 1661 (SEQ ID NO:340), GHPO 1673 (SEQ ID NO:342), GHPO 1687 (SEQ ID NO:344), GHPO 1692 (SEQ ID NO:346), GHPO 1693 (SEQ ID NO:348), GHPO 1699 (SEQ ID NO:350), GHPO 1738 (SEQ ID NO:352), GHPO 1745 (SEQ ID NO:354), GHPO 1746 (SEQ ID NO:356), GHPO 1754 (SEQ ID NO:358), GHPO 1792 (SEQ ID NO:360), GHPO 1795 (SEQ ID NO:362), and GHPO 1796 (SEQ ID NO:364); or
(ii) a derivative of said Helicobacter polypeptide.

### Claim 2 (depends on 1)

The isolated polynucleotide of claim 1, which encodes a mature form of said Helicobacter polypeptide.

### Claim 3 (depends on 1)

The isolated polynucleotide of claim 1, wherein the polynucleotide is a DNA molecule.

### Claim 4 (depends on 1)

The isolated polynucleotide of claim 1, which is a DNA molecule that can be amplified by polymerase chain reaction from a Helicobacter genome.

### Claim 5 (depends on 4)

The isolated DNA molecule of claim 4, which can be amplified by the polymerase chain reaction from a Helicobacter pylori genome.

### Claim 6 (depends on 1, 4)

The isolated polynucleotide of claim 1, which is a DNA molecule that encodes the mature form or a derivative of a polypeptide encoded by the DNA molecule of claim 4.

### Claim 7 (depends on 1, 5)

The isolated polynucleotide of claim 1, which is a DNA molecule that encodes the mature form or a derivative of a polypeptide encoded by the DNA molecule of claim 5.

### Claim 8

A compound, in a substantially purified form, that is the mature form or a derivative of a polypeptide comprising an amino acid sequence that is homologous to a Helicobacter polypeptide selected from the group consisting of GHPO 15 (SEQ ID NO:2), GHPO 16 (SEQ ID NO:4), GHPO 36 (SEQ ID NO:6), GHPO 38 (SEQ ID NO:8), GHPO 52 (SEQ ID NO:10), GHPO 57 (SEQ ID NO:12), GHPO 64 (SEQ ID NO:14), GHPO 79 (SEQ ID NO:16), GHPO 84 (SEQ ID NO:18), GHPO 86 (SEQ ID NO:20), GHPO 99 (SEQ ID NO:22), GHPO 106 (SEQ ID NO:24), GHPO 118 (SEQ ID NO:26), GHPO 122 (SEQ ID NO:28), GHPO 128 (SEQ ID NO:30), GHPO 138 (SEQ ID NO:32), GHPO 153 (SEQ ID NO:34), GHPO 160 (SEQ ID NO:36), GHPO 168 (SEQ ID NO:38), GHPO 179 (SEQ ID NO:40), GHPO 189 (SEQ ID NO:42), GHPO 229 (SEQ ID NO:44), GHPO 243 (SEQ ID NO:46), GHPO 244 (SEQ ID NO:48), GHPO 251 (SEQ ID NO:50), GHPO 267 (SEQ ID NO:52), GHPO 269 (SEQ ID NO:54), GHPO 279 (SEQ ID NO:56), GHPO 284 (SEQ ID NO:58), GHPO 296 (SEQ ID NO:60), GHPO 300 (SEQ ID NO:62), GHPO 305 (SEQ ID NO:64), GHPO 319 (SEQ ID NO:66), GHPO 330 (SEQ ID NO:68), GHPO 340 (SEQ ID NO:70), GHPO 342 (SEQ ID NO:72), GHPO 344 (SEQ ID NO:74), GHPO 358 (SEQ ID NO:76), GHPO 373 (SEQ ID NO:78), GHPO 382 (SEQ ID NO:80), GHPO 384 (SEQ ID NO:82), GHPO 398 (SEQ ID NO:84), GHPO 409 (SEQ ID NO:86), GHPO 422 (SEQ ID NO:88), GHPO 430 (SEQ ID NO:90), GHPO 446 (SEQ ID NO:92), GHPO 447 (SEQ ID NO:94), GHPO 450 (SEQ ID NO:96), GHPO 451 (SEQ ID NO:98), GHPO 452 (SEQ ID NO:100), GHPO 456 (SEQ ID NO:102), GHPO 461 (SEQ ID NO:104), GHPO 476 (SEQ ID NO:106), GHPO 478 (SEQ ID NO:108), GHPO 491 (SEQ ID NO:110), GHPO 511 (SEQ ID NO:112), GHPO 519 (SEQ ID NO:114), GHPO 526 (SEQ ID NO:116), GHPO 534 (SEQ ID NO:118), GHPO 536 (SEQ ID NO:120), GHPO 542 (SEQ ID NO:122), GHPO 544 (SEQ ID NO:124), GHPO 576 (SEQ ID NO:126), GHPO 578 (SEQ ID NO:128), GHPO 580 (SEQ ID NO:130), GHPO 585 (SEQ ID NO:132), GHPO 599 (SEQ ID NO:134), GHPO 639 (SEQ ID NO:136), GHPO 642 (SEQ ID NO:138), GHPO 647 (SEQ ID NO:140), GHPO 654 (SEQ ID NO:142), GHPO 669 (SEQ ID NO:144), GHPO 710 (SEQ ID NO:146), GHPO 713 (SEQ ID NO:148), GHPO 716 (SEQ ID NO:150), GHPO 718 (SEQ ID NO:152), GHPO 726 (SEQ ID NO:154), GHPO 734 (SEQ ID NO:156), GHPO 740 (SEQ ID NO:158), GHPO 770 (SEQ ID NO:160), GHPO 782 (SEQ ID NO:162), GHPO 786 (SEQ ID NO:164), GHPO 792 (SEQ ID NO:166), GHPO 797 (SEQ ID NO:168), GHPO 816 (SEQ ID NO:170), GHPO 828 (SEQ ID NO:172), GHPO 839 (SEQ ID NO:174), GHPO 840 (SEQ ID NO:176), GHPO 842 (SEQ ID NO:178), GHPO 885 (SEQ ID NO:180), GHPO 889 (SEQ ID NO:182), GHPO 903 (SEQ ID NO:184), GHPO 912 (SEQ ID NO:186), GHPO 946 (SEQ ID NO:188), GHPO 958 (SEQ ID NO:190), GHPO 968 (SEQ ID NO:192), GHPO 987 (SEQ ID NO:194), GHPO 992 (SEQ ID NO:196), GHPO 996 (SEQ ID NO:198), GHPO 997 (SEQ ID NO:200), GHPO 1002 (SEQ ID NO:202), GHPO 1026 (SEQ ID NO:204), GHPO 1028 (SEQ ID NO:206), GHPO 1034 (SEQ ID NO:208), GHPO 1038 (SEQ ID NO:210), GHPO 1059 (SEQ ID NO:212), GHPO 1065 (SEQ ID NO:214), GHPO 1072 (SEQ ID NO:216), GHPO 1073 (SEQ ID NO:218), GHPO 1088 (SEQ ID NO:220), GHPO 1091 (SEQ ID NO:222), GHPO 1105 (SEQ ID NO:224), GHPO 1115 (SEQ ID NO:226), GHPO 1159 (SEQ ID NO:228), GHPO 1177 (SEQ ID NO:230), GHPO 1187 (SEQ ID NO:232), GHPO 1192 (SEQ ID NO:234), GHPO 1195 (SEQ ID NO:236), GHPO 1224 (SEQ ID NO:238), GHPO 1225 (SEQ ID NO:240), GHPO 1228 (SEQ ID NO:242), GHPO 1229 (SEQ ID NO:244), GHPO 1231 (SEQ ID NO:246), GHPO 1236 (SEQ ID NO:248), GHPO 1242 (SEQ ID NO:250), GHPO 1248 (SEQ ID NO:252), GHPO 1270 (SEQ ID NO:254), GHPO 1271 (SEQ ID NO:256), GHPO 1298 (SEQ ID NO:258), GHPO 1301 (SEQ ID NO:260), GHPO 1304 (SEQ ID NO:262), GHPO 1315 (SEQ ID NO:264), GHPO 1319 (SEQ ID NO:266), GHPO 1323 (SEQ ID NO:268), GHPO 1331 (SEQ ID NO:270), GHPO 1332 (SEQ ID NO:272), GHPO 1347 (SEQ ID NO:274), GHPO 1373 (SEQ ID NO:276), GHPO 1376 (SEQ ID NO:278), GHPO 1380 (SEQ ID NO:280), GHPO 1394 (SEQ ID NO:282), GHPO 1407 (SEQ ID NO:284), GHPO 1415 (SEQ ID NO:286), GHPO 1425 (SEQ ID NO:288), GIIPO 1427 (SEQ ID NO:290), GHPO 1444 (SEQ ID NO:292), GHPO 1449 (SEQ ID NO:294), GHPO 1465 (SEQ ID NO:296), GHPO 1475 (SEQ ID NO:298), GHPO 1479 (SEQ ID NO:300), GHPO 1483 (SEQ ID NO:302), GHPO 1488 (SEQ ID NO:304), GHPO 1496 (SEQ ID NO:306), GHPO 1524 (SEQ ID NO:308), GHPO 1536 (SEQ ID NO:310), GHPO 1539 (SEQ ID NO:312), GHPO 1540 (SEQ ID NO:314), GHPO 1542 (SEQ ID NO:316), GHPO 1555 (SEQ ID NO:318), GHPO 1560 (SEQ ID NO:320), GHPO 1564 (SEQ ID NO:322), GHPO 1570 (SEQ ID NO:324), GHPO 1588 (SEQ ID NO:326), GHPO 1604 (SEQ ID NO:328), GHPO 1605 (SEQ ID NO:330), GHPO 1619 (SEQ ID NO:332), GHPO 1629 (SEQ ID NO:334), GHPO 1642 (SEQ ID NO:336), GHPO 1654 (SEQ ID NO:338), GHPO 1661 (SEQ ID NO:340), GHPO 1673 (SEQ ID NO:342), GHPO 1687 (SEQ ID NO:344), GHPO 1692 (SEQ ID NO:346), GHPO 1693 (SEQ ID NO:348), GHPO 1699 (SEQ ID NO:350), GHPO 1738 (SEQ ID NO:352), GHPO 1745 (SEQ ID NO:354), GHPO 1746 (SEQ ID NO:356), GHPO 1754 (SEQ ID NO:358), GHPO 1792 (SEQ ID NO:360), GHPO 1795 (SEQ ID NO:362), and GHPO 1796 (SEQ ID NO:364); or
(ii) a derivative of said Helicobacter polypeptide.

### Claim 9 (depends on 4, 8)

The compound of claim 8, which is the mature form or a derivative of a polypeptide encoded by a DNA molecule of claim 4.

### Claim 10 (depends on 5, 8)

The compound of claim 8, which is the mature form or a derivative of a polypeptide encoded by a DNA molecule of claim 5.

### Claim 11 (depends on 8)

A method of preventing or treating Helicobacter infection in a mammal, said method comprising administering to said mammal a prophylactically or therapeutically effective amount of a compound of claim 8.

### Claim 12 (depends on 11)

The method of claim 11, further comprising administering to said mammal an antibiotic, an antisecretory agent, a bismuth salt, or a combination thereof.

### Claim 13 (depends on 12)

The method of claim 12, wherein said antibiotic is selected from the group consisting of amoxicillin, clarithromycin, tetracycline, metronidizole, and erythromycin.

### Claim 14 (depends on 12)

The method of claim 12, wherein said bismuth salt is selected from the group consisting of bismuth subcitrate and bismuth subsalicylate.

### Claim 15 (depends on 12)

The method of claim 12, wherein said antisecretory agent is a proton pump inhibitor.

### Claim 16 (depends on 15)

The method of claim 15, wherein said proton pump inhibitor is selected from the group consisting of omeprazole, lansoprazole, and pantoprazole.

### Claim 17 (depends on 12)

The method of claim 12, wherein said antisecretory agent is an H2-receptor antagonist.

### Claim 18 (depends on 17)

The method of claim 17, wherein said H2-receptor antagonist is selected from the group consisting of ranitidine, cimetidine, famotidine, nizatidine, and roxatidine.

### Claim 19 (depends on 12)

The method of claim 12, wherein said antisecretory agent is a prostaglandin analog.

### Claim 20 (depends on 19)

The method of claim 19, wherein said prostaglandin analog is misoprostil or enprostil.

### Claim 21 (depends on 11)

The method of claim 11, further comprising administering to said mammal a prophylactically or therapeutically effective amount of a second Helicobacter polypeptide or a derivative thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein the second Helicobacter polypeptide is a Helicobacter urease, or a subunit or a derivative thereof.

### Claim 23 (depends on 8)

A composition comprising a compound of claim 8, together with a physiologically acceptable diluent or carrier.

### Claim 24 (depends on 23)

The composition of claim 23, further comprising an adjuvant.

### Claim 25 (depends on 23)

The composition of claim 23, further comprising a second Helicobacter polypeptide or a derivative thereof.

### Claim 26 (depends on 25)

The composition of claim 25, wherein said second Helicobacter polypeptide is a Helicobacter urease, or a subunit or a derivative thereof.

### Claim 27 (depends on 1)

A method of preventing or treating Helicobacter infection in a mammal, said method comprising administering to said mammal a prophylactically or therapeutically effective amount of a polynucleotide of claim 1.

### Claim 28 (depends on 4)

A method of preventing or treating Helicobacter infection in a mammal, said method comprising administering to said mammal a prophylactically or therapeutically effective amount of a polynucleotide of claim 4.

### Claim 29 (depends on 7)

A method of preventing or treating Helicobacter infection in a mammal, said method comprising administering to said mammal a prophylactically or therapeutically effective amount of a polynucleotide of claim 7.

### Claim 30 (depends on 3)

A composition comprising a viral vector, in the genome of which is inserted a DNA molecule of claim 3, said DNA molecule being placed under conditions for expression in a mammalian cell and said viral vector being admixed with a physiologically acceptable diluent or carrier.

### Claim 31 (depends on 30)

The composition of claim 30, wherein said viral vector is a poxvirus.

### Claim 32 (depends on 3)

A composition that comprises a bacterial vector comprising a DNA molecule of claim 3, said DNA molecule being placed under conditions for expression and said bacterial vector being admixed with a physiologically acceptable diluent or carrier.

### Claim 33 (depends on 32)

The composition of claim 32, wherein said vector is selected from the group consisting of Shigella, Salmonella, Vibrio cholerae, Lactobacillus, Bacille bilié de Calmette-Guérin, and Streptococcus.

### Claim 34 (depends on 1)

A composition comprising a polynucleotide of claim 1, together with a physiologically acceptable diluent or carrier.

### Claim 35 (depends on 34)

The composition of claim 34, wherein said polynucleotide is a DNA molecule that is inserted in a plasmid that is unable to replicate and to substantially integrate in a mammalian genome and is placed under conditions for expression in a mammalian cell.

### Claim 36 (depends on 3)

An expression cassette comprising a DNA molecule of claim 3, said DNA molecule being placed under conditions for expression in a procaryotic or eucaryotic cell.

### Claim 37 (depends on 8, 36)

A process for producing a compound of claim 8, which comprises culturing a procaryotic or eucaryotic cell transformed or transfected with an expression cassette of claim 36, and recovering said compound from the cell culture.

### Claim 38 (depends on 8)

A method of preventing or treating Helicobacter infection in a mammal, said method comprising administering to said mammal a prophylactically or therapeutically effective amount of an antibody that binds to the compound of claim 8.
